Result: Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: a study on behalf of the EBMT and the GoCART coalition

*Title*:

*Author/editor-in-chief*:

*Publication*:

Freiburg : Universität, 2025

*Physical description scale*:

1 Online-Ressource

*Format*:

*eBook*

*Language*:

*eng*

*Notes*:

HemaSphere. - 9, 5 (2025) , e70146, ISSN: 2572-9241

*DOI*:

10.1002/hem3.70146

*Result*: Efficacy and safety of CAR T-cell therapy in patients with primary or secondary CNS lymphoma: a study on behalf of the EBMT and the GoCART coalition